![David Bejker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Bejker
Director/Board Member at ABLIVA AB
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Eskil Elmér | M | 54 | 24 years | |
Catharina Jz Johansson | F | 57 | 11 years | |
Carl Erik Mathias Uhlén | M | 70 |
Affibody AB
![]() Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden.
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 26 years |
Karin Hansson | M | 61 |
Amylonix AB
![]() Amylonix AB Pharmaceuticals: MajorHealth Technology Amylonix AB develops pharmaceuticals focused on the neurodegenerative area. Amylonix AB is based in Johanneshov, Sweden. It was founded in 2018 by Karin Marianne Hansson, who has been the CEO since 2018. | 6 years |
David Laskow-Pooley | M | 70 | 8 years | |
Karin Nord | M | - |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 26 years |
Stig Anders Lindberg | M | 52 |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.
Affibody AB
![]() Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | - |
Johan Stuart | M | 67 |
Affibody AB
![]() Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | - |
Jan Birger Fredrik Toernell | M | 64 | 7 years | |
Denise Goode | F | 66 | 6 years | |
Joachim Feldwisch | M | - |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Eleonor Asander Frostner | F | 43 | 13 years | |
Camilla Soenderby | F | - |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Gillian Cannon | M | 60 |
Affibody AB
![]() Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | 5 years |
Ellen Donnelly | M | 50 | 3 years | |
Magnus Hansson | M | 48 | 16 years | |
Jose F. Suarez | M | 54 |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Roger Franklin | M | 45 | 4 years | |
Karl Anders Axel Swartling | M | 59 |
Affibody AB
![]() Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | - |
Anders Martin-Löf | M | 53 |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 3 years |
Robert Forbes Burns | M | 77 |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Björn Christian Oker-Blom | M | 60 |
Disruptive Pharma Holding AB
| - |
J. Kenneth Charles Knowles | M | 77 |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Erik Walldén | M | 75 |
Affibody AB
![]() Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | - |
Dag Nesse | M | 58 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Anna Yvonne Monica Malm Bernsten | F | 63 | 4 years | |
Marie Helena Levander | F | 67 | 5 years | |
Gunnar Magnus Modee Persson | M | 64 | 2 years | |
Derek Gregory Batcheller | M | 67 | 17 years | |
Arne Ferstad | M | 74 | 7 years | |
Erik Kinnman | M | 66 | 5 years | |
Matilda Hugerth | F | 49 | 5 years | |
Boel Flodgren | M | 82 | 4 years | |
Marcus Keep | M | 65 | 18 years | |
Mark Farmery | M | 55 | 3 years | |
Daniel Schale | M | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 36 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Bejker
- Personal Network